1. Home
  2. TRUG vs PPBT Comparison

TRUG vs PPBT Comparison

Compare TRUG & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUG
  • PPBT
  • Stock Information
  • Founded
  • TRUG 1983
  • PPBT 2010
  • Country
  • TRUG United States
  • PPBT Israel
  • Employees
  • TRUG N/A
  • PPBT N/A
  • Industry
  • TRUG
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUG
  • PPBT Health Care
  • Exchange
  • TRUG NYSE
  • PPBT Nasdaq
  • Market Cap
  • TRUG 12.7M
  • PPBT 9.2M
  • IPO Year
  • TRUG N/A
  • PPBT N/A
  • Fundamental
  • Price
  • TRUG $0.94
  • PPBT $4.20
  • Analyst Decision
  • TRUG
  • PPBT Strong Buy
  • Analyst Count
  • TRUG 0
  • PPBT 2
  • Target Price
  • TRUG N/A
  • PPBT $126.50
  • AVG Volume (30 Days)
  • TRUG 16.7K
  • PPBT 50.4K
  • Earning Date
  • TRUG 10-15-2024
  • PPBT 11-19-2024
  • Dividend Yield
  • TRUG N/A
  • PPBT N/A
  • EPS Growth
  • TRUG N/A
  • PPBT N/A
  • EPS
  • TRUG N/A
  • PPBT N/A
  • Revenue
  • TRUG $19,112,071.00
  • PPBT N/A
  • Revenue This Year
  • TRUG N/A
  • PPBT N/A
  • Revenue Next Year
  • TRUG N/A
  • PPBT N/A
  • P/E Ratio
  • TRUG N/A
  • PPBT N/A
  • Revenue Growth
  • TRUG N/A
  • PPBT N/A
  • 52 Week Low
  • TRUG $0.79
  • PPBT $3.76
  • 52 Week High
  • TRUG $11.82
  • PPBT $36.00
  • Technical
  • Relative Strength Index (RSI)
  • TRUG 42.79
  • PPBT 28.28
  • Support Level
  • TRUG $0.79
  • PPBT $3.76
  • Resistance Level
  • TRUG $1.00
  • PPBT $5.92
  • Average True Range (ATR)
  • TRUG 0.09
  • PPBT 0.65
  • MACD
  • TRUG 0.00
  • PPBT -0.13
  • Stochastic Oscillator
  • TRUG 52.86
  • PPBT 14.86

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: